Novel approaches to treating advanced systemic mastocytosis
JA Gilreath,1 L Tchertanov,2 MW Deininger31Department of Pharmacotherapy, College of Pharmacy and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA; 2Centre de Mathématiques et de Leurs Applications (CMLA-CNRS), ENS Paris-Saclay, Cachan 94235, France; 3Division...
Main Authors: | Gilreath JA, Tchertanov L, Deininger MW |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | Clinical Pharmacology : Advances and Applications |
Subjects: | |
Online Access: | https://www.dovepress.com/novel-approaches-to-treating-advanced-systemic-mastocytosis-peer-reviewed-article-CPAA |
Similar Items
-
Avapritinib: a new tyrosine kinase inhibitor for treatment of advanced gastrointestinal stromal tumors. The literature review and clinical case
by: Daria A. Filonenko, et al.
Published: (2021-02-01) -
Response Criteria in Advanced Systemic Mastocytosis: Evolution in the Era of KIT Inhibitors
by: William Shomali, et al.
Published: (2021-03-01) -
Targeted Treatment Options in Mastocytosis
by: Mélanie Vaes, et al.
Published: (2017-07-01) -
Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap
by: Miguel Piris-Villaespesa, et al.
Published: (2020-04-01) -
Clinical potential of midostaurin in advanced systemic mastocytosis
by: Chandesris MO, et al.
Published: (2017-05-01)